Hillgene Won the BioCon Awards [Annual CDMO Excellence Award]

On September 6, BioCon Expo 2022, the 9th International Biopharmaceutical Conference and Exhibition, was held as scheduled at the Hangzhou International Expo Center. The BioCon Awards Ceremony and the 10th Anniversary Appreciation Banquet of Shangtu also started at 17:30 on the evening of the 6th. As the winner of the [Annual Outstanding CDMO Honor Award], Spectrum Biopharma accepted the invitation of the conference and attended the award ceremony that evening.

This conference set up four awards: the most valuable biotechnology company, the annual outstanding founder of the biotechnology industry, the annual outstanding CDMO honor award, and the annual future star of the bio-industry park. Based on the results of expert review and public voting, Spectrum Biotech won the [Annual Outstanding CDMO Honor Award] with its outstanding strength.

Spectrum Biopharma focuses on the unique CQDMO innovative service model in the field of cell drugs. While deepening its cell therapy CDMO services, it has built a quality control platform targeting the needs of each stage of cell drug industrialization based on industry pain points and needs, and officially launched a CQDMO service system with "quality" as the core.

This honor for Spectrum Biosciences fully demonstrates that we have been working hard to become the industry's leading provider of cell-based drug solutions and to accelerate the introduction of more cell-based drugs to the market. In the future, Spectrum Biosciences will double its responsibility and continue to pursue higher levels of development, continuously innovate its technology platform, and benefit more patients.